- Coultreon banks $125M to support testing of former Galapagos immune drug<figure><div><img src="https://imgproxy.divecdn.com/8Ke9WrBxrjriIMo_u4dl_2_uFBzNkadEM2l-qjoKTeQ/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDk2NTQxMDExLmpwZ…BioPharma Dive · 3mo ago↗ source
- Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.<p>Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to investors, som…BioPharma Dive · 3mo ago↗ source
- Oruka surges as long-acting psoriasis drug shows early promise<figure><div><img src="https://imgproxy.divecdn.com/sygPNZ6Z-9Em079kzacqYUfZZEIau6u7hunPxNpWFgw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDk3Nzk0NDI4LmpwZ…